Plasmonic two-nanopore technology for single-molecule protein sequencing (Acronym: TwoPoreProSeq)

Description of the granted funding

While portable single-molecule DNA sequencers have been brought to African and Brazil villages for sequencing Ebola and Zika virus, no corresponding technologies exist for protein sequencing. The big gap hampers not only mechanistic studies but also clinical applications. The latter includes digital health and personalized medicine that aims to provide customized treatment to individual patients based on dynamic personal health data collected by Point-of-care diagnostic devices. The TwoPoreProSeq project aims to develop a novel plasmonic two-nanopore device able to unfold and sequence single protein molecules by plasmon-enhanced Raman spectroscopy. It can provide a single-molecule protein sequencing technology to Point-of-Care devices, allowing peoples in both developed and underdeveloped countries to acquire data of their health and diseases at home for health management.
Show more

Starting year

2022

End year

2027

Granted funding

Jianan Huang Orcid -palvelun logo
447 650 €

Related funding decisions

368482
Research costs of Academy Research Fellows(2025)
159 771 €
353776
Research costs of Academy Research Fellows(2022)
240 000 €

Funder

Research Council of Finland

Funding instrument

Academy research fellows

Decision maker

Scientific Council for Natural Sciences and Engineering
12.05.2022

Other information

Funding decision number

347652

Fields of science

Nanotechnology

Research fields

Nanotiede ja -tekniikka

Identified topics

genes, genetics